Semax

• 5mg lyophilized peptide
• 30mg lyophilized peptide

• Neuroprotection and BDNF stimulation, increasing brain-derived neurotrophic factor (BDNF) signaling to support neuronal growth, repair, and synaptic plasticity.
• Cognitive enhancement through modulation of dopamine, serotonin, and acetylcholine systems, supporting memory, focus, and learning capacity.
• Anti-stress and HPA axis regulation through effects on the hypothalamic-pituitary-adrenal (HPA) axis, which may reduce stress, anxiety, and mental fatigue signals.

Semax is commonly studied for

• Cognitive enhancement signals including improved memory retention, mental clarity, and focus, often discussed in performance-demanding contexts.
• Stress and fatigue reduction signals, supporting lower perceived mental and physical strain in high-demand environments.
• Neurological recovery support signals in research frameworks involving stroke, traumatic brain injury (TBI), and neurodegenerative conditions, tied to broader brain resilience endpoints.

Semax is generally described as well tolerated with minimal side effects in research settings. Semax is commonly described as not having sedative effects or dependence risk in the researcg, which is why it is often positioned as an alternative to traditional stimulants or anxiolytics in these discussions.

• Mild nasal irritation can occur with intranasal administration.
• Headaches can occur, particularly at higher doses.
• Mild overstimulation can occur, especially if taken later in the day.

• Often paired with Selank for synergistic cognitive effects in research applications
• May complement SS-31, MOTS-C, NAD+, Methylene Blue, Dihexa in neuroprotection research
• No negative interactions documented in research models